1	Use	Use	B-NP	NN	O	0	ROOT	0
2	of	of	B-PP	IN	O	1	NMOD	-1
3	uteroglobin	uteroglobin	B-NP	NN	O	2	PMOD	-1
4	for	for	B-PP	IN	O	1	NMOD	-1
5	the	the	B-NP	DT	O	6	NMOD	-1
6	engineering	engineering	I-NP	NN	O	4	PMOD	-1
7	of	of	B-PP	IN	O	6	NMOD	-1
8	polyvalent	polyvalent	B-NP	JJ	O	7	PMOD	-1
9	,	,	I-NP	,	O	8	P	-1
10	polyspecific	polyspecific	I-NP	JJ	B-protein	12	NMOD	-1
11	fusion	fusion	I-NP	NN	I-protein	12	NMOD	0
12	proteins	protein	I-NP	NNS	I-protein	8	NMOD	-1
13	.	.	O	.	O	1	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	report	report	B-VP	VBP	O	0	ROOT	-1
3	a	a	B-NP	DT	O	5	NMOD	-1
4	novel	novel	I-NP	JJ	O	5	NMOD	-1
5	strategy	strategy	I-NP	NN	O	2	OBJ	-1
6	to	to	B-PP	TO	O	5	NMOD	-1
7	engineer	engineer	B-NP	NN	O	6	PMOD	-1
8	and	and	O	CC	O	2	VMOD	-1
9	express	express	B-VP	VBP	O	2	VMOD	0
10	stable	stable	B-NP	JJ	O	12	AMOD	-1
11	and	and	I-NP	CC	O	12	AMOD	-1
12	soluble	soluble	I-NP	JJ	O	9	OBJ	-1
13	human	human	I-NP	JJ	B-protein	15	AMOD	-1
14	recombinant	recombinant	I-NP	JJ	I-protein	15	AMOD	-1
15	polyvalent/polyspecific	polyvalent/polyspecific	I-NP	JJ	I-protein	12	NMOD	-1
16	fusion	fusion	I-NP	NN	I-protein	17	NMOD	0
17	proteins	protein	I-NP	NNS	I-protein	12	NMOD	-1
18	.	.	O	.	O	2	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	procedure	procedure	I-NP	NN	O	3	SUB	-1
3	is	be	B-VP	VBZ	O	0	ROOT	-1
4	based	base	I-VP	VBN	O	3	VC	-1
5	on	on	B-PP	IN	O	4	VMOD	-1
6	the	the	B-NP	DT	O	7	NMOD	-1
7	use	use	I-NP	NN	O	5	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	-1
9	a	a	B-NP	DT	O	11	NMOD	-1
10	central	central	I-NP	JJ	O	11	NMOD	-1
11	skeleton	skeleton	I-NP	NN	O	8	PMOD	-1
12	of	of	B-PP	IN	O	11	NMOD	-1
13	uteroglobin	uteroglobin	B-NP	NN	B-protein	19	NMOD	-1
14	,	,	O	,	O	19	P	-1
15	a	a	B-NP	DT	O	16	NMOD	-1
16	small	small	I-NP	JJ	O	19	NMOD	-1
17	and	and	O	CC	O	19	AMOD	-1
18	very	very	B-ADJP	RB	O	19	AMOD	-1
19	soluble	soluble	I-ADJP	JJ	O	21	AMOD	-1
20	covalently	covalently	B-VP	RB	O	21	AMOD	-1
21	linked	link	I-VP	VBN	O	23	NMOD	0
22	homodimeric	homodimeric	B-NP	JJ	B-protein	23	NMOD	-1
23	protein	protein	I-NP	NN	I-protein	12	PMOD	-1
24	that	that	B-NP	WDT	O	23	NMOD	-1
25	is	be	B-VP	VBZ	O	24	SBAR	-1
26	very	very	B-ADJP	RB	O	27	AMOD	-1
27	resistant	resistant	I-ADJP	JJ	O	25	PRD	-1
28	to	to	B-PP	TO	O	27	AMOD	-1
29	proteolytic	proteolytic	B-NP	JJ	B-protein	30	NMOD	-1
30	enzymes	enzyme	I-NP	NNS	I-protein	28	PMOD	-1
31	and	and	B-PP	CC	O	28	PMOD	-1
32	to	to	B-PP	TO	O	28	PMOD	-1
33	pH	pH	B-NP	NN	O	34	NMOD	-1
34	variations	variation	I-NP	NNS	O	32	PMOD	-1
35	.	.	O	.	O	3	P	-1

1	Using	Use	B-VP	VBG	O	33	VMOD	-1
2	a	a	B-NP	DT	O	5	NMOD	-1
3	human	human	I-NP	JJ	B-protein	5	NMOD	-1
4	recombinant	recombinant	I-NP	JJ	I-protein	5	NMOD	-1
5	antibody	antibody	I-NP	NN	I-protein	24	NMOD	-1
6	(	(	O	(	O	8	DEP	-1
7	scFv	scFv	B-NP	NN	O	8	DEP	-1
8	)	)	O	)	O	5	NMOD	-1
9	specific	specific	B-ADJP	JJ	O	5	NMOD	-1
10	for	for	B-PP	IN	O	9	AMOD	-1
11	the	the	B-NP	DT	O	15	NMOD	-1
12	angiogenesis	angiogenesis	I-NP	NN	O	15	NMOD	3	angiogenesis
13	marker	marker	I-NP	NN	O	15	NMOD	-1
14	domain	domain	I-NP	NN	O	15	NMOD	-1
15	B	B	I-NP	NN	O	10	PMOD	-1
16	of	of	B-PP	IN	O	15	NMOD	-1
17	fibronectin	fibronectin	B-NP	NN	B-protein	16	PMOD	-1
18	,	,	O	,	O	24	P	-1
19	interleukin	interleukin	B-NP	NN	B-protein	24	NMOD	-1
20	2	2	I-NP	CD	I-protein	19	NMOD	-1
21	,	,	O	,	O	24	P	-1
22	and	and	O	CC	O	24	NMOD	-1
23	an	an	B-NP	DT	O	24	NMOD	-1
24	scFv	scFv	I-NP	NN	O	1	OBJ	-1
25	able	able	B-ADJP	JJ	O	24	NMOD	-1
26	to	to	B-VP	TO	O	27	VMOD	-1
27	neutralize	neutralize	I-VP	VB	O	25	AMOD	18	neutralize
28	tumor	tumor	B-NP	NN	B-protein	30	NMOD	-1
29	necrosis	necrosis	I-NP	NN	I-protein	30	NMOD	0
30	factor-alpha	factor-alpha	I-NP	NN	I-protein	27	OBJ	-1
31	,	,	O	,	O	33	P	-1
32	we	we	B-NP	PRP	O	33	SUB	-1
33	expressed	express	B-VP	VBD	O	0	ROOT	0
34	various	various	B-NP	JJ	O	36	AMOD	-1
35	biologically	biologically	I-NP	RB	O	36	AMOD	-1
36	active	active	I-NP	JJ	O	39	NMOD	-1
37	uteroglobin	uteroglobin	I-NP	NN	B-protein	39	NMOD	-1
38	fusion	fusion	I-NP	NN	I-protein	39	NMOD	0
39	proteins	protein	I-NP	NNS	I-protein	33	OBJ	-1
40	.	.	O	.	O	33	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	results	result	I-NP	NNS	O	3	SUB	0
3	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	-1
4	the	the	B-NP	DT	O	5	NMOD	-1
5	possibility	possibility	I-NP	NN	O	20	NMOD	-1
6	to	to	B-VP	TO	O	7	VMOD	-1
7	generate	generate	I-VP	VB	O	5	NMOD	-1
8	monospecific	monospecific	B-NP	JJ	O	12	NMOD	-1
9	divalent	divalent	I-NP	JJ	O	12	NMOD	-1
10	and	and	I-NP	CC	O	12	NMOD	-1
11	tetravalent	tetravalent	I-NP	JJ	B-protein	12	NMOD	-1
12	antibodies	antibody	I-NP	NNS	I-protein	7	OBJ	-1
13	,	,	O	,	O	20	P	-1
14	immunocytokines	immunocytokine	B-NP	NNS	B-protein	20	NMOD	-1
15	,	,	O	,	O	20	P	-1
16	and	and	O	CC	O	20	NMOD	-1
17	dual	dual	B-NP	JJ	O	20	NMOD	-1
18	specificity	specificity	I-NP	NN	O	20	NMOD	-1
19	tetravalent	tetravalent	I-NP	JJ	O	20	NMOD	-1
20	antibodies	antibody	I-NP	NNS	O	3	OBJ	-1
21	.	.	O	.	O	3	P	-1

1	Furthermore	Furthermore	B-ADVP	RB	O	19	VMOD	-1
2	,	,	O	,	O	19	P	-1
3	compared	compare	B-PP	VBN	O	19	VMOD	-1
4	with	with	B-PP	IN	O	3	PMOD	-1
5	similar	similar	B-NP	JJ	O	7	NMOD	-1
6	fusion	fusion	I-NP	NN	B-protein	7	NMOD	0
7	proteins	protein	I-NP	NNS	I-protein	4	PMOD	-1
8	in	in	B-PP	IN	O	7	NMOD	-1
9	which	which	B-NP	WDT	O	8	PMOD	-1
10	uteroglobin	uteroglobin	B-NP	NN	O	11	SUB	-1
11	was	be	B-VP	VBD	O	8	SBAR	-1
12	not	not	I-VP	RB	O	11	VMOD	-1
13	used	use	I-VP	VBN	O	11	VC	0
14	,	,	O	,	O	19	P	-1
15	the	the	B-NP	DT	O	16	NMOD	-1
16	use	use	I-NP	NN	O	19	SUB	0
17	of	of	B-PP	IN	O	16	NMOD	-1
18	uteroglobin	uteroglobin	B-NP	NN	O	17	PMOD	-1
19	improved	improve	B-VP	VBD	O	0	ROOT	0
20	properties	property	B-NP	NNS	O	19	OBJ	0
21	of	of	B-PP	IN	O	20	NMOD	-1
22	solubility	solubility	B-NP	NN	O	24	NMOD	-1
23	and	and	I-NP	CC	O	24	NMOD	-1
24	stability	stability	I-NP	NN	O	21	PMOD	-1
25	.	.	O	.	O	19	P	-1

1	Indeed	Indeed	B-ADVP	RB	O	8	VMOD	-1
2	,	,	O	,	O	8	P	-1
3	in	in	B-PP	IN	O	8	VMOD	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	reported	report	I-NP	VBN	O	6	NMOD	-1
6	cases	case	I-NP	NNS	O	3	PMOD	-1
7	it	it	B-NP	PRP	O	8	SUB	-1
8	was	be	B-VP	VBD	O	0	ROOT	-1
9	possible	possible	B-ADJP	JJ	O	8	PRD	-1
10	to	to	B-VP	TO	O	11	VMOD	-1
11	vacuum	vacuum	I-VP	VB	O	8	VMOD	-1
12	dry	dry	B-NP	JJ	O	11	OBJ	-1
13	and	and	O	CC	O	11	VMOD	-1
14	reconstitute	reconstitute	B-VP	VB	O	11	VMOD	-1
15	the	the	B-NP	DT	O	16	NMOD	-1
16	proteins	protein	I-NP	NNS	O	14	OBJ	-1
17	without	without	B-PP	IN	O	14	VMOD	-1
18	any	any	B-NP	DT	O	21	NMOD	-1
19	aggregation	aggregation	I-NP	NN	O	21	NMOD	0
20	or	or	I-NP	CC	O	21	NMOD	-1
21	loss	loss	I-NP	NN	O	17	PMOD	0
22	in	in	B-PP	IN	O	21	NMOD	-1
23	protein	protein	B-NP	NN	O	26	NMOD	-1
24	and	and	O	CC	O	26	NMOD	-1
25	biological	biological	B-NP	JJ	O	26	NMOD	-1
26	activity	activity	I-NP	NN	O	22	PMOD	0
